PCPE-1, a brown adipose tissue-derived cytokine, promotes obesity-induced liver fibrosis

Author:

Hsiao Yung Ting,Yoshida Yohko,Okuda Shujiro,Abe ManabuORCID,Mizuno SeiyaORCID,Takahashi SatoruORCID,Nakagami HironoriORCID,Morishita Ryuichi,Kamimura KenyaORCID,Terai ShujiORCID,Aung Tin MayORCID,Li Ji,Furihata Takaaki,Tang Jing Yuan,Walsh Kenneth,Ishigami AkihitoORCID,Minamino TohruORCID,Shimizu IppeiORCID

Abstract

AbstractMetabolic dysfunction-associated steatohepatitis (MASH, previously termed non-alcoholic steatohepatitis (NASH)), is a major complication of obesity that promotes fatty liver disease. MASH is characterized by progressive tissue fibrosis and sterile liver inflammation that can lead to liver cirrhosis, cancer, and death. The molecular mechanisms of fibrosis in MASH and its systemic control remain poorly understood. Here, we identified the secreted-type pro-fibrotic protein, procollagen C-endopeptidase enhancer-1 (PCPE-1), as a brown adipose tissue (BAT)-derived adipokine that promotes liver fibrosis in a murine obesity-induced MASH model. BAT-specific or systemic PCPE-1 depletion in mice ameliorated liver fibrosis, whereas, PCPE-1 gain of function in BAT enhanced hepatic fibrosis. High-calorie diet-induced ER stress increased PCPE-1 production in BAT through the activation of IRE-1/JNK/c-Fos/c-Jun signaling. Circulating PCPE-1 levels are increased in the plasma of MASH patients, suggesting a therapeutic possibility. In sum, our results uncover PCPE-1 as a novel systemic control factor of liver fibrosis.

Funder

MEXT | Japan Science and Technology Agency

MEXT | Japan Society for the Promotion of Science

Japan Agency for Medical Research and Development

National Cerebral and Cardiovascular Center

Daiichi Sankyo Company

Roche Holding | Chugai Pharmaceutical

Uehara Memorial Foundation

Kowa Life Science Foundation

Manpei Suzuki Diabetes Foundation

MSD Life Science Foundation, Public Interest Incorporated Foundation

Kanae Foundation for the Promotion of Medical Science

Inamori Foundation

Terumo Foundation for Life Sciences and Arts

SENSHIN Medical Research Foundation

Ono Medical Research Foundation

Heiwa Nakajima Foundation

Suzuken Memorial Foundation

Hokuto Foundation for Bioscience

Mochida Memorial Foundation for Medical and Pharmaceutical Research

Cell Science Research Foundation

Daiichi Sankyo Foundation of Life Science

Tokyo Biochemical Research Foundation

Astellas Foundation for Research on Metabolic Disorders

Naito Foundation

Japan Geriatrics Society

Japan Diabetes Foundation

Kobayashi Magobei Memorial Medical Promotion Foundation of Japan

President's Grant for Interfaculty Collaboration Juntendo University

Japanese Circulation Society Grant for Future-Pioneering Doctors for Basic Research

Life Science Foundation of Japan

grant from Bourbon

Japan Foundation for Applied Enzymology

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3